Details for Australian Trade Mark No. 1202356 (hide)

Owner GTC Biotherapeutics, Inc.

Convention US 22 March 2007 77137845

Various Convention priority claimed: 22 March 2007, United States of America, No. 77137845 in respect of CUSTOM MANUFACTURE OF TRANSGENIC ANIMAL PRODUCTS, NAMELY, PHARMACEUTICALS, BIOPHARMACEUTICALS AND PROTEINS in class 40.* Convention priority claimed: 27 April

Filing Date 2 July 2007

Classes

Class 5 Transgenic animal products, namely antithrombin for therapeutic and diagnostic use

Class 40 Custom manufacture of transgenic animal products, namely, pharmaceuticals, biopharmaceuticals and proteins

Event Publications

8 November 2007 Application Accepted

6 March 2008 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1202357

1202355-DALCOS